Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 418624, 11 pages
http://dx.doi.org/10.1155/2014/418624
Research Article

Gold Nanoparticles Inhibit VEGF165-Induced Migration and Tube Formation of Endothelial Cells via the Akt Pathway

1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China
2Department of Histology and Embryology, Medical School of Jinan University, Guangzhou 510632, China
3Department of Chemistry, Life Science and Technology School of Jinan University, Guangzhou 510632, China
4Department of Pathology, Medical School of Jinan University, Guangzhou 510632, China
5Division of Clinic Pathology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China

Received 5 February 2014; Revised 27 April 2014; Accepted 28 April 2014; Published 1 June 2014

Academic Editor: Gagan Deep

Copyright © 2014 Yunlong Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Ferrara, “Vascular endothelial growth factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 789–791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Folkman and Y. Shing, “Angiogenesis,” Journal of Biological Chemistry, vol. 267, no. 16, pp. 10931–10934, 1992. View at Google Scholar · View at Scopus
  4. N. Ferrara, “VEGF-A: a critical regulator of blood vessel growth,” European Cytokine Network, vol. 20, no. 4, pp. 158–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Lamalice, F. Houle, and J. Huot, “Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF,” Journal of Biological Chemistry, vol. 281, no. 45, pp. 34009–34020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Lamalice, F. Le Boeuf, and J. Huot, “Endothelial cell migration during angiogenesis,” Circulation Research, vol. 100, no. 6, pp. 782–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ferrara, K. J. Hillan, and W. Novotny, “Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy,” Biochemical and Biophysical Research Communications, vol. 333, no. 2, pp. 328–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Taugourdeau-Raymond, F. Rouby, A. Default, and M.-J. Jean-Pastor, “Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database,” European Journal of Clinical Pharmacology, vol. 68, no. 7, pp. 1103–1107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Sun, Y. Liu, Q. Yu et al., “The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling,” Biomaterials, vol. 34, no. 1, pp. 171–180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Jain, D. G. Hirst, and J. M. O'Sullivan, “Gold nanoparticles as novel agents for cancer therapy,” British Journal of Radiology, vol. 85, no. 1010, pp. 101–113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D.-S. Hsieh, H.-C. Lu, C.-C. Chen, C.-J. Wu, and M.-K. Yeh, “The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system,” International Journal of Nanomedicine, vol. 7, pp. 1623–1633, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Bhattacharya, P. Mukherjee, Z. Xiong, A. Atala, S. Soker, and D. Mukhopadhyay, “Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells,” Nano Letters, vol. 4, no. 12, pp. 2479–2481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Pan, H. Ding, L. Qin et al., “Gold nanoparticles induce nanostructural reorganization of VEGFR2 to repress angiogenesis,” Journal of Biomedical Nanotechnology, vol. 9, no. 10, pp. 1746–1756, 2013. View at Google Scholar
  14. X. Ji, X. Song, J. Li, Y. Bai, W. Yang, and X. Peng, “Size control of gold nanocrystals in citrate reduction: the third role of citrate,” Journal of the American Chemical Society, vol. 129, no. 45, pp. 13939–13948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Izuta, Y. Chikaraishi, M. Shimazawa et al., “10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 4, pp. 489–494, 2009. View at Google Scholar
  16. M. H. Pourgholami, L. M. Khachigian, R. G. Fahmy et al., “Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis,” Biochemical and Biophysical Research Communications, vol. 397, no. 4, pp. 729–734, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Ke, H. Jin, and J. Cai, “AFM studied the effect of celastrol on β1 integrin-mediated HUVEC adhesion and migration,” Scanning, vol. 35, no. 5, pp. 316–326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Pi, H. Jin, R. Liu et al., “Pathway of cytotoxicity induced by folic acid modified selenium nanoparticles in MCF-7 cells,” Applied Microbiology and Biotechnology, vol. 97, no. 3, pp. 1051–1062, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. F. T. Cezar-De-Mello, V. Nascimento-Silva, C. G. Villela, and I. M. Fierro, “Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly,” Oncogene, vol. 25, no. 1, pp. 122–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Wang, Y. Yin, W. Li et al., “Over-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway,” PLoS ONE, vol. 7, no. 2, Article ID e30503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, “Vascular-specific growth factors and blood vessel formation,” Nature, vol. 407, no. 6801, pp. 242–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mukherjee, R. Bhattacharya, P. Wang et al., “Antiangiogenic properties of gold nanoparticles,” Clinical Cancer Research, vol. 11, no. 9, pp. 3530–3534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Gao, N. Lu, Y. Ling et al., “Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 5, pp. 667–675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. S. Sharma, R. Sharma, and T. Tyagi, “VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future,” Current Cancer Drug Targets, vol. 11, no. 5, pp. 624–653, 2011. View at Google Scholar · View at Scopus
  25. H.-Y. Xu, Y.-M. Pan, Z.-W. Chen et al., “12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway,” Journal of Ethnopharmacology, vol. 146, no. 3, pp. 724–733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Kim, M. H. Kim, D. H. Jo, Y. S. Yu, T. G. Lee, and J. H. Kim, “The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation,” Biomaterials, vol. 32, no. 7, pp. 1865–1871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Graupera and M. Potente, “Regulation of angiogenesis by PI3K signaling networks,” Experimental Cell Research, vol. 319, no. 9, pp. 1348–1355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. B. D. Manning and L. C. Cantley, “AKT/PKB signaling: navigating downstream,” Cell, vol. 129, no. 7, pp. 1261–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Müller and Y. F. Dufrêne, “Atomic force microscopy: a nanoscopic window on the cell surface,” Trends in Cell Biology, vol. 21, no. 8, pp. 461–469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Jin, J. Pi, X. Huang et al., “BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation,” Applied Microbiology and Biotechnology, vol. 93, no. 4, pp. 1715–1723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Le Grimellec, E. Lesniewska, M.-C. Giocondi, E. Finot, V. Vié, and J.-P. Goudonnet, “Imaging of the surface of living cells by low-force contact-mode atomic force microscopy,” Biophysical Journal, vol. 75, no. 2, pp. 695–703, 1998. View at Google Scholar · View at Scopus